Klaus Jung

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

Annika Schaefer, Monika Jung, Hans‐Joachim Mollenkopf et al. · International Journal of Cancer · 2009 · 613 citations · Full text

Microrna Profiling, Prognostic Biomarkers, Urology +13

Betaine Improves the PCR Amplification of GC-Rich DNA Sequences

Wolfgang Henke, K. Herdel, Klaus Jung et al. · Nucleic Acids Research · 1997 · 515 citations · Full text

Genetics, Secondary Structure, Dna Analysis +16

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

Wilko Weichert, A.-E. Roske, Volker Gekeler et al. · British Journal of Cancer · 2008 · 474 citations · Full text

Histone Modifications, Chromatin, Hdac Inhibitors +15

Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial

Manfred Johannsen, Uwe Gneveckow, Kasra Taymoorian et al. · International Journal of Hyperthermia · 2007 · 368 citations

Robust MicroRNA Stability in Degraded RNA Preparations from Human Tissue and Cell Samples

Monika Jung, Annika Schaefer, Isabel Steiner et al. · Clinical Chemistry · 2010 · 295 citations · Full text